Clinically proven to reduce the effects of CSA

The remedē^® System is a breakthrough implantable system that safely and effectively treats moderate to severe central sleep apnea (CSA) in adult patients.¹

• Stimulates a more normal breathing pattern: By stimulating the phrenic nerve the remedē System activates the diaphragm, a physiologic mechanism similar to natural breathing
• Automatic and continuous treatment: The system activates automatically at night, removing the need for patient interaction and alleviating patient compliance concerns
• Sustained benefits: 81% reduction in the mean of the central apnea index from baseline to 6 months (versus an 11% reduction in the control group)¹ and 93% reduction at 12 months.²
• Recommended by patients: 95% of patients in the pivotal trial reported they would “elect to have the medical procedure again”²
• The remedē EL-X is the latest advancement in remedē System technology, with enhancements and new features including:
  • Extended Longevity: the remedē EL-X battery life extended by 40% from previous model² (under typical settings)
  • Patient-friendly design: the size of the remedē EL-X decreased by 25% from previous model²
  • Redesigned as a one lead, one port system: Single lead delivers stimulation and senses
  • Data-driven clinical insights with DRēAM View: An addition to remedē Reports, DRēAM View delivers full-night, detailed diagnostic capabilities.